基因组编辑
去甲基化
基因
化学
核酸内切酶
亚基因组mRNA
Cas9
细胞生物学
生物
翻译(生物学)
计算生物学
分子生物学
干扰素
DNA去甲基化
DNA
基因表达
引导RNA
核糖核酸
遗传增强
甲基化
RNA编辑
HEK 293细胞
癌症研究
RNA干扰
生物化学
基因靶向
胞苷
基因表达调控
DNA甲基化
作者
Haoyu Zhang,Yajie Li,Yehan Wang,Ziyin Zhao,Yang He,Jiawen Hu,Desheng Cao,Guanglin Wang,Ran Zhu,Xun Liu,Lichen Yin
摘要
Spatiotemporal precision remains a critical challenge against the gene editing technology used for disease treatment. We herein developed a tumor cell-selective CRISPR/Cas9 gene editing system by introducing a complementary single-stranded DNA (ssDNA) containing apurinic/apyrimidinic (AP) sites (AP-ssDNA) along the target region of single-guided RNA (sgRNA). The engineered hybrid (AP-ssDNA/sgRNA) could tracelessly release the native sgRNA in tumor cells due to cleavage of AP-ssDNA by the overexpressed apurinic/apyrimidinic endonuclease 1 (APE1), thus enabling tumor-selective gene editing. Subsequently, a biodegradable lipid nanoparticle based on dynamic covalent bonding was developed to codeliver Cas9-encoding mRNA (mCas9) with AP-ssDNA/sgRNA targeting the SUV39H1 gene, which mediated silence of cyclic GMP-AMP synthase (cGAS) methylation to activate stimulator of interferon genes (STING) and enhanced antitumor immunity. As thus, when coupled with radiotherapy, the gene editing platform provoked robust antitumor efficacy in B16F10 xenograft tumor-bearing mice. This study provides a versatile paradigm for conditionally controlled gene editing and highlights the therapeutic potential of cGAS demethylation in reactivating cGAS-STING pathway for antitumor immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI